Drug Trial Radar · NCT00005775
Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants
Last checked: Nov 19, 2026Latest source record: Jun 8, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,433
Actual
Start
Jul 1999
Primary completion
Dec 2000
Study completion Aug 2001
Sponsor
- Lead sponsor
- NICHD Neonatal Research NetworkResearch network
- Sponsor type
- Research network
- Collaborators
- National Center for Research Resources (NCRR)
- First posted
- Jun 2, 2000
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Single group
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, up to 72 hours
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This large multicenter double-masked clinical trial tested whether supplementation of standard neonatal parenteral nutrition with glutamine would reduce the risk of death or late-onset sepsis in extremely-low-birth-weight (ELBW, less than or equal to 1000 gm) infants. Neonates with birth weights of 401-1000gm were randomized to standard TrophAmine or TrophAmine supplemented with glutamine before 72 hours and continued until the infants are tolerating full enteral feedings.
Conditions
- Infant, Newborn
- Infant, Low Birth Weight
- Infant, Small for Gestational Age
- Infant, Premature
- Sepsis
Interventions
GlutamineDrug
Infants randomized to glutamine supplementation will receive glutamine any time that parenteral nutrition is required during the first 120 days of hospitalization.
PlaceboDrug
TrophAmine given any time that parenteral nutrition is required during the first 120 days of hospitalization.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Death or late-onset sepsisTime frame: At hospital discharge
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Stanford University
Palo Alto, California
University of California at San Diego
San Diego, California
Yale University
New Haven, Connecticut
University of Miami
Miami, Florida
Emory University
Atlanta, Georgia
Indiana University
Indianapolis, Indiana
Wayne State University
Detroit, Michigan
University of New Mexico
Albuquerque, New Mexico
RTI International
Durham, North Carolina
Cincinnati Children's Medical Center
Cincinnati, Ohio
Case Western Reserve University, Rainbow Babies and Children's Hospital
Cleveland, Ohio
Brown University, Women & Infants Hospital of Rhode Island
Providence, Rhode Island
University of Texas Southwestern Medical Center at Dallas
Dallas, Texas
University of Texas Health Science Center at Houston
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.